These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18931536)

  • 1. Single-measurement therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, lamivudine, efavirenz, nevirapine, lopinavir and nelfinavir.
    Donnerer J; Haas BJ; Kessler HH
    Pharmacology; 2008; 82(4):287-92. PubMed ID: 18931536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
    Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
    Colombo S; Telenti A; Buclin T; Furrer H; Lee BL; Biollaz J; Decosterd LA;
    Ther Drug Monit; 2006 Jun; 28(3):332-8. PubMed ID: 16778716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, efavirenz, nevirapine, indinavir, lopinavir, and nelfinavir.
    Donnerer J; Kronawetter M; Kapper A; Haas I; Kessler HH
    Pharmacology; 2003 Dec; 69(4):197-204. PubMed ID: 14624060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
    Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
    J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.
    Rakhmanina NY; Capparelli EV; van den Anker JN; Williams K; Sever JL; Spiegel HM; Soldin SJ
    Ther Drug Monit; 2007 Feb; 29(1):110-7. PubMed ID: 17304158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
    Pawiński T; Pulik P; Gralak B; Horban A
    Acta Pol Pharm; 2008; 65(1):93-100. PubMed ID: 18536180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
    Fabbiani M; Di Giambenedetto S; Bracciale L; Bacarelli A; Ragazzoni E; Cauda R; Navarra P; De Luca A
    J Antimicrob Chemother; 2009 Jul; 64(1):109-17. PubMed ID: 19398461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
    Dubé MP; Parker RA; Mulligan K; Tebas P; Robbins GK; Roubenoff R; Grinspoon SK
    Clin Infect Dis; 2007 Jul; 45(1):120-6. PubMed ID: 17554712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in Rwanda.
    Gras A; Schneider S; Karasi JC; Ternes AM; Sauvageot N; Karasi-Omes C; Henry AP; Schmit JC; Seguin-Devaux C; Arendt V
    Curr HIV Res; 2011 Jun; 9(4):223-8. PubMed ID: 21671885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.
    Antinori A; Perno CF; Giancola ML; Forbici F; Ippolito G; Hoetelmans RM; Piscitelli SC
    Clin Infect Dis; 2005 Dec; 41(12):1787-93. PubMed ID: 16288405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands.
    van Luin M; Wit FW; Smit C; Rigter IM; Franssen EJ; Richter C; Kroon F; de Wolf F; Burger DM
    Ther Drug Monit; 2011 Feb; 33(1):32-9. PubMed ID: 21192311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
    De Clercq E
    Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
    Dailly E; Raffi F; Jolliet P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):353-8. PubMed ID: 15556553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy.
    Pereira SA; Branco T; Caixas U; Côrte-Real RM; Germano I; Lampreia F; Monteiro EC
    Ther Drug Monit; 2008 Feb; 30(1):60-6. PubMed ID: 18223464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
    Panhard X; Legrand M; Taburet AM; Diquet B; Goujard C; Mentré F;
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1019-29. PubMed ID: 17694300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of nevirapine in resource-limited settings.
    L'homme RF; Muro EP; Droste JA; Wolters LR; van Ewijk-Beneken Kolmer NW; Schimana W; Burger DM
    Clin Infect Dis; 2008 Nov; 47(10):1339-44. PubMed ID: 18922070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patterns of antiretroviral drug prescription in 997 Colombian patients].
    Machado JE; Alzate JA
    Biomedica; 2008 Mar; 28(1):78-86. PubMed ID: 18645663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
    J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.